chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: had one Moderna shot a couple of months ago and didn't get second one; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 23-Jul-2021 and was forwarded to Moderna on 23-Jul-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (had one Moderna shot a couple of months ago and didn't get second one) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (had one Moderna shot a couple of months ago and didn't get second one). At the time of the report, PRODUCT DOSE OMISSION ISSUE (had one Moderna shot a couple of months ago and didn't get second one) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided by the reporter. No treatment medications were provided by the reporter.   Reporter did not allow further contact
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Anosmia
Clinical narrative: Could not smell anything; This spontaneous case was reported by a consumer and describes the occurrence of ANOSMIA (Could not smell anything) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030M20A and 028L20A) for COVID-19 vaccination.     No medical history was not provided by reporter.  Concomitant products included LEVOTHYROXINE SODIUM (LEVOTHYROXIN) for an unknown indication.   On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 20-Jul-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced ANOSMIA (Could not smell anything). At the time of the report, ANOSMIA (Could not smell anything) outcome was unknown.
Age: 41.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: dose was administered after 12 hours of puncturing the vial; This spontaneous case was reported by a consumer and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (dose was administered after 12 hours of puncturing the vial) in a 41-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jul-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (dose was administered after 12 hours of puncturing the vial). On 23-Jul-2021, EXPIRED PRODUCT ADMINISTERED (dose was administered after 12 hours of puncturing the vial) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Vial was stored on the refrigerator on Sunday 18July2021 in the Morning. The vial was punctured at 6 pm on 22-Jul-2021.  This was the first dose of the patient, and patient had no symptoms after the administration.   No concomitant medications were reported.  No treatment medications were reported.
Sex: F
Vaccine: COVID19
Symptoms: Incomplete course of vaccination
Clinical narrative: Expired of first shot; This spontaneous case was reported by a consumer and describes the occurrence of INCOMPLETE COURSE OF VACCINATION (Expired of first shot) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INCOMPLETE COURSE OF VACCINATION (Expired of first shot). At the time of the report, INCOMPLETE COURSE OF VACCINATION (Expired of first shot) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product used was not provided by the reporter.  This patient reported if the first shot is expired, do they have to have two shots?  Treatment  information is not provided..   Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: 1st does of covid vaccine was 6 weeks ago; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (1st does of covid vaccine was 6 weeks ago) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (1st does of covid vaccine was 6 weeks ago). At the time of the report, PRODUCT DOSE OMISSION ISSUE (1st does of covid vaccine was 6 weeks ago) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No concomitant medication were reported. No treatment information was reported.   Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Infertility female, Pain
Clinical narrative: Pain; Fertility test showed no eggs; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Pain) and INFERTILITY FEMALE (Fertility test showed no eggs) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN (Pain) and INFERTILITY FEMALE (Fertility test showed no eggs). At the time of the report, PAIN (Pain) and INFERTILITY FEMALE (Fertility test showed no eggs) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No concomitant and treatment medications were provided
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Pruritus, Urticaria, Vaccination site pain
Clinical narrative: Hives (right side on shoulder); Itchiness; Headache; Fatigue; Pain at injection site, Soreness at injection site; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (Hives (right side on shoulder)), PRURITUS (Itchiness), HEADACHE (Headache), FATIGUE (Fatigue) and VACCINATION SITE PAIN (Pain at injection site, Soreness at injection site) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036C21A) for COVID-19 vaccination.     Concurrent medical conditions included Latex allergy and Drug allergy (Minocycline Allergy.).    On 24-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Jul-2021, the patient experienced URTICARIA (Hives (right side on shoulder)), PRURITUS (Itchiness), HEADACHE (Headache), FATIGUE (Fatigue) and VACCINATION SITE PAIN (Pain at injection site, Soreness at injection site). At the time of the report, URTICARIA (Hives (right side on shoulder)), PRURITUS (Itchiness), HEADACHE (Headache), FATIGUE (Fatigue) and VACCINATION SITE PAIN (Pain at injection site, Soreness at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication not reported No treatment information was not provided
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Erythema, Fatigue, Myalgia, Pain in extremity
Clinical narrative: pink area that is slightly itchy; pink area that is slightly itchy; Soreness on her arm; fever; fatigue; body ache; stabbing pain in her elbow area after the injection; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (pink area that is slightly itchy), PRURITUS (pink area that is slightly itchy), PAIN IN EXTREMITY (Soreness on her arm), PYREXIA (fever) and FATIGUE (fatigue) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 051C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Blood pressure high. Concomitant products included CLONIDINE for Blood pressure high, ATENOLOL, ACETYLSALICYLIC ACID (BABY ASPIRIN) and SIMVASTATIN for an unknown indication.   On 20-Jul-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jul-2021, the patient experienced PAIN IN EXTREMITY (Soreness on her arm), PYREXIA (fever), FATIGUE (fatigue), MYALGIA (body ache) and ARTHRALGIA (stabbing pain in her elbow area after the injection). On 23-Jul-2021, the patient experienced ERYTHEMA (pink area that is slightly itchy) and PRURITUS (pink area that is slightly itchy). At the time of the report, ERYTHEMA (pink area that is slightly itchy) and PRURITUS (pink area that is slightly itchy) had not resolved and PAIN IN EXTREMITY (Soreness on her arm), PYREXIA (fever), FATIGUE (fatigue), MYALGIA (body ache) and ARTHRALGIA (stabbing pain in her elbow area after the injection) had resolved.            Patient was unsure about dose-1 date and bath number. Patient stated that date could be 18 or 22 Jun and the batch number could be 026D21A or 086D21A. She sprayed some alcohol on her arm.  Treatment information was not provided.   This case was linked to MOD-2021-265327 (Patient Link).
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Pyrexia
Clinical narrative: pink area that is slightly itchy; pink area that is slightly itchy; Soreness on her arm; fever; fatigue; body ache; stabbing pain in her elbow area after the injection; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (pink area that is slightly itchy), PRURITUS (pink area that is slightly itchy), PAIN IN EXTREMITY (Soreness on her arm), PYREXIA (fever) and FATIGUE (fatigue) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 051C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Blood pressure high. Concomitant products included CLONIDINE for Blood pressure high, ATENOLOL, ACETYLSALICYLIC ACID (BABY ASPIRIN) and SIMVASTATIN for an unknown indication.   On 20-Jul-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jul-2021, the patient experienced PAIN IN EXTREMITY (Soreness on her arm), PYREXIA (fever), FATIGUE (fatigue), MYALGIA (body ache) and ARTHRALGIA (stabbing pain in her elbow area after the injection). On 23-Jul-2021, the patient experienced ERYTHEMA (pink area that is slightly itchy) and PRURITUS (pink area that is slightly itchy). At the time of the report, ERYTHEMA (pink area that is slightly itchy) and PRURITUS (pink area that is slightly itchy) had not resolved and PAIN IN EXTREMITY (Soreness on her arm), PYREXIA (fever), FATIGUE (fatigue), MYALGIA (body ache) and ARTHRALGIA (stabbing pain in her elbow area after the injection) had resolved.            Patient was unsure about dose-1 date and bath number. Patient stated that date could be 18 or 22 Jun and the batch number could be 026D21A or 086D21A. She sprayed some alcohol on her arm.  Treatment information was not provided.   This case was linked to MOD-2021-265327 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: strange symptoms/Side effect; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 25-Jul-2021 and was forwarded to Moderna on 25-Jul-2021.    This spontaneous case was reported by a patient and describes the occurrence of VACCINATION COMPLICATION (strange symptoms/Side effect) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (strange symptoms/Side effect). At the time of the report, VACCINATION COMPLICATION (strange symptoms/Side effect) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       no treatment drugs included no concomitant drugs included
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Vaccination site pruritus
Clinical narrative: Itching at the injection site; Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Itching at the injection site) and MYALGIA (Sore arm) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 078C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Jul-2021, the patient experienced MYALGIA (Sore arm). On 20-Jul-2021, the patient experienced VACCINATION SITE PRURITUS (Itching at the injection site). At the time of the report, VACCINATION SITE PRURITUS (Itching at the injection site) and MYALGIA (Sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient was taking other medication. HCP was not aware of the symptoms. Treatment information was not reported.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, Product storage error
Clinical narrative: Administered with the vaccine which has been stored in the refrigerator for more than 30 days; Administered with the vaccine which has been stored in the refrigerator for more than 30 days; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administered with the vaccine which has been stored in the refrigerator for more than 30 days) and PRODUCT STORAGE ERROR (Administered with the vaccine which has been stored in the refrigerator for more than 30 days) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 19-Jul-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Jul-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administered with the vaccine which has been stored in the refrigerator for more than 30 days) and PRODUCT STORAGE ERROR (Administered with the vaccine which has been stored in the refrigerator for more than 30 days). On 19-Jul-2021, EXPIRED PRODUCT ADMINISTERED (Administered with the vaccine which has been stored in the refrigerator for more than 30 days) and PRODUCT STORAGE ERROR (Administered with the vaccine which has been stored in the refrigerator for more than 30 days) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication reported. No treatment information was provided.   This case was linked to MOD-2021-265450 (Patient Link).
Age: 41.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity, Product dose omission issue
Clinical narrative: After the first dose he had a sore arm for 24 hours; Caller received 1st dose of the Moderna vaccine on 21Mar2021 on his left arm at County Health Department and was unable to receive 2nd dose; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (After the first dose he had a sore arm for 24 hours   ) and PRODUCT DOSE OMISSION ISSUE (Caller received 1st dose of the Moderna vaccine on 21Mar2021 on his left arm at County Health Department and was unable to receive 2nd dose) in a 41-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010AC1A) for COVID-19 vaccination.     Concomitant products included ESCITALOPRAM for an unknown indication.    On 21-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (After the first dose he had a sore arm for 24 hours   ) and PRODUCT DOSE OMISSION ISSUE (Caller received 1st dose of the Moderna vaccine on 21Mar2021 on his left arm at County Health Department and was unable to receive 2nd dose). At the time of the report, PAIN IN EXTREMITY (After the first dose he had a sore arm for 24 hours   ) and PRODUCT DOSE OMISSION ISSUE (Caller received 1st dose of the Moderna vaccine on 21Mar2021 on his left arm at County Health Department and was unable to receive 2nd dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter did not allow further contact
Sex: U
Vaccine: COVID19
Symptoms: Dysgeusia, Hyposmia, Pruritus, Vaccination complication
Clinical narrative: Itchy; metal taste reduced smell.reactions; metal taste reduced smell.reactions; very hard reaction to the shot; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itchy), DYSGEUSIA (metal taste reduced smell.reactions), HYPOSMIA (metal taste reduced smell.reactions) and VACCINATION COMPLICATION (very hard reaction to the shot) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRURITUS (Itchy), DYSGEUSIA (metal taste reduced smell.reactions), HYPOSMIA (metal taste reduced smell.reactions) and VACCINATION COMPLICATION (very hard reaction to the shot). At the time of the report, PRURITUS (Itchy), DYSGEUSIA (metal taste reduced smell.reactions), HYPOSMIA (metal taste reduced smell.reactions) and VACCINATION COMPLICATION (very hard reaction to the shot) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided.  No treatment information were provided.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, Dysgeusia, Headache, Urticaria
Clinical narrative: Hives on Arms \ Hives on Legs; loss of taste; loss of smell; metallic taste; headache; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (Hives on Arms \ Hives on Legs), AGEUSIA (loss of taste), ANOSMIA (loss of smell), DYSGEUSIA (metallic taste) and HEADACHE (headache) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M20H) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Feb-2021, the patient experienced URTICARIA (Hives on Arms \ Hives on Legs), AGEUSIA (loss of taste), ANOSMIA (loss of smell), DYSGEUSIA (metallic taste) and HEADACHE (headache). On 20-Mar-2021, URTICARIA (Hives on Arms \ Hives on Legs) had resolved. At the time of the report, AGEUSIA (loss of taste), ANOSMIA (loss of smell), DYSGEUSIA (metallic taste) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications was reported. No treatment information was provided   This case was linked to MOD-2021-265646 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of vaccination complication (side effects getting worse) in a patient, of an unknown age and gender, who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. No medical history reported. In July 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. In 2021, patient experienced vaccination complication (side effects getting worse). At the time of the report, vaccination complication (side effects getting worse) outcome: unknown. The action taken with mRNA-1273 (Moderna COVID-19 vaccine), intramuscular: unknown. The patient's side effects seemed to get worse and a little better at times. No concomitant medication or treatment information reported.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: had the same side effect from the Moderna COVID19 vaccine that lasted upto week; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (had the same side effect from the Moderna COVID19 vaccine that lasted upto week) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (had the same side effect from the Moderna COVID19 vaccine that lasted upto week). At the time of the report, VACCINATION COMPLICATION (had the same side effect from the Moderna COVID19 vaccine that lasted upto week) had resolved.            Concomitant medications was not reported.  Treatment medications was not reported.    This case was linked to MOD-2021-265482 (Patient Link).   Reporter did not allow further contact
Sex: M
Vaccine: COVID19
Symptoms: Blood glucose decreased, Exposure via breast milk
Clinical narrative: Low glucose at birth, corrected in 12 hours; Vaccine Exposure Via Breast Milk; This spontaneous case was reported by a consumer and describes the occurrence of BLOOD GLUCOSE DECREASED (Low glucose at birth, corrected in 12 hours) and EXPOSURE VIA BREAST MILK (Vaccine Exposure Via Breast Milk) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included PROPRANOLOL HYDROCHLORIDE (PROPANOLOL) for Anxiety.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced BLOOD GLUCOSE DECREASED (Low glucose at birth, corrected in 12 hours) and EXPOSURE VIA BREAST MILK (Vaccine Exposure Via Breast Milk). At the time of the report, BLOOD GLUCOSE DECREASED (Low glucose at birth, corrected in 12 hours) had resolved and EXPOSURE VIA BREAST MILK (Vaccine Exposure Via Breast Milk) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   No treatment was received by the patient
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Fatigue, Illness, Limb discomfort, Muscle spasms
Clinical narrative: Low energy; Leg problem; Pain in their left legs/leg pain; Feeling Fatigue; Cramps in their left legs; 3 weeks sick after 2nd shot; This spontaneous case was reported by a consumer and describes the occurrence of MUSCLE SPASMS (Cramps in their left legs), ILLNESS (3 weeks sick after 2nd shot), ASTHENIA (Low energy), LIMB DISCOMFORT (Leg problem) and PAIN IN EXTREMITY (Pain in their left legs/leg pain) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013L20A and 013L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Blood pressure high and Cholesterol since 1978. Concomitant products included LOSARTAN and ATENOLOL for Blood pressure high, SIMVASTATIN for Cholesterol, VITAMIN D NOS for Vitamin supplementation.   On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Feb-2021, the patient experienced ILLNESS (3 weeks sick after 2nd shot). On an unknown date, the patient experienced MUSCLE SPASMS (Cramps in their left legs), ASTHENIA (Low energy), LIMB DISCOMFORT (Leg problem), PAIN IN EXTREMITY (Pain in their left legs/leg pain) and FATIGUE (Feeling Fatigue). At the time of the report, MUSCLE SPASMS (Cramps in their left legs), ILLNESS (3 weeks sick after 2nd shot), ASTHENIA (Low energy), LIMB DISCOMFORT (Leg problem) and FATIGUE (Feeling Fatigue) had not resolved and PAIN IN EXTREMITY (Pain in their left legs/leg pain) outcome was unknown.            Most recent FOLLOW-UP information incorporated above includes: On 03-Aug-2021: Follow-up information received contains patient initials and details,current conditions, suspect drug(dose 1 and 2 details),concomitant drugs and events(3 weeks sick after second shot, feeling fatigue, low energy and leg pain) added.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Low energy; Leg problem; Pain in their left legs/leg pain; Feeling Fatigue; Cramps in their left legs; 3 weeks sick after 2nd shot; This spontaneous case was reported by a consumer and describes the occurrence of MUSCLE SPASMS (Cramps in their left legs), ILLNESS (3 weeks sick after 2nd shot), ASTHENIA (Low energy), LIMB DISCOMFORT (Leg problem) and PAIN IN EXTREMITY (Pain in their left legs/leg pain) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013L20A and 013L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Blood pressure high and Cholesterol since 1978. Concomitant products included LOSARTAN and ATENOLOL for Blood pressure high, SIMVASTATIN for Cholesterol, VITAMIN D NOS for Vitamin supplementation.   On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Feb-2021, the patient experienced ILLNESS (3 weeks sick after 2nd shot). On an unknown date, the patient experienced MUSCLE SPASMS (Cramps in their left legs), ASTHENIA (Low energy), LIMB DISCOMFORT (Leg problem), PAIN IN EXTREMITY (Pain in their left legs/leg pain) and FATIGUE (Feeling Fatigue). At the time of the report, MUSCLE SPASMS (Cramps in their left legs), ILLNESS (3 weeks sick after 2nd shot), ASTHENIA (Low energy), LIMB DISCOMFORT (Leg problem) and FATIGUE (Feeling Fatigue) had not resolved and PAIN IN EXTREMITY (Pain in their left legs/leg pain) outcome was unknown.            Most recent FOLLOW-UP information incorporated above includes: On 03-Aug-2021: Follow-up information received contains patient initials and details,current conditions, suspect drug(dose 1 and 2 details),concomitant drugs and events(3 weeks sick after second shot, feeling fatigue, low energy and leg pain) added.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: How long can side effects last after the shot; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (How long can side effects last after the shot) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (How long can side effects last after the shot). At the time of the report, VACCINATION COMPLICATION (How long can side effects last after the shot) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications was reported.  Treatment information was not provided.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Contusion, Fatigue, Feeling abnormal, Illness
Clinical narrative: she got sick; she did not feel good; Terrible bruise which was 2inch diameter/stayed with her for a long time; She had fatigue; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (she got sick), FEELING ABNORMAL (she did not feel good), CONTUSION (Terrible bruise which was 2inch diameter/stayed with her for a long time) and FATIGUE (She had fatigue) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Mar-2021, the patient experienced ILLNESS (she got sick), FEELING ABNORMAL (she did not feel good), CONTUSION (Terrible bruise which was 2inch diameter/stayed with her for a long time) and FATIGUE (She had fatigue). At the time of the report, ILLNESS (she got sick), FEELING ABNORMAL (she did not feel good), CONTUSION (Terrible bruise which was 2inch diameter/stayed with her for a long time) and FATIGUE (She had fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient bruise stayed with her for a long time. Patient had taken Concomitant medication for Blood pressure, cholesterol and something for her stomach.   This case was linked to MOD-2021-265659 (Patient Link).
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, Chills, Dysgeusia, Myalgia
Clinical narrative: hives continued; achy feeling in her upper body; metallic taste; itching; Neck Ache; loss of smell; loss of taste; metallic taste; fever; chills; This spontaneous case was reported by a consumer and describes the occurrence of ANOSMIA (loss of smell), AGEUSIA (loss of taste), the second episode of DYSGEUSIA (metallic taste), PRURITUS (itching) and NECK PAIN (Neck Ache) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 016M20H and 032M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 06-Mar-2021, the patient experienced ANOSMIA (loss of smell), AGEUSIA (loss of taste), PYREXIA (fever), CHILLS (chills) and the first episode of DYSGEUSIA (metallic taste). On 19-Jul-2021, the patient experienced the second episode of DYSGEUSIA (metallic taste), PRURITUS (itching), NECK PAIN (Neck Ache) and MYALGIA (achy feeling in her upper body). On an unknown date, the patient experienced URTICARIA (hives continued). On 09-Mar-2021, ANOSMIA (loss of smell), AGEUSIA (loss of taste), PYREXIA (fever) and CHILLS (chills) had resolved. At the time of the report, last episode of DYSGEUSIA (metallic taste), PRURITUS (itching) and MYALGIA (achy feeling in her upper body) had not resolved and NECK PAIN (Neck Ache) and URTICARIA (hives continued) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment reported.  No concomitant medication reported.   This case was linked to MOD-2021-265616 (Patient Link).   Reporter did not allow further contact
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Neck pain, Pruritus, Pyrexia, Urticaria
Clinical narrative: hives continued; achy feeling in her upper body; metallic taste; itching; Neck Ache; loss of smell; loss of taste; metallic taste; fever; chills; This spontaneous case was reported by a consumer and describes the occurrence of ANOSMIA (loss of smell), AGEUSIA (loss of taste), the second episode of DYSGEUSIA (metallic taste), PRURITUS (itching) and NECK PAIN (Neck Ache) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 016M20H and 032M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 06-Mar-2021, the patient experienced ANOSMIA (loss of smell), AGEUSIA (loss of taste), PYREXIA (fever), CHILLS (chills) and the first episode of DYSGEUSIA (metallic taste). On 19-Jul-2021, the patient experienced the second episode of DYSGEUSIA (metallic taste), PRURITUS (itching), NECK PAIN (Neck Ache) and MYALGIA (achy feeling in her upper body). On an unknown date, the patient experienced URTICARIA (hives continued). On 09-Mar-2021, ANOSMIA (loss of smell), AGEUSIA (loss of taste), PYREXIA (fever) and CHILLS (chills) had resolved. At the time of the report, last episode of DYSGEUSIA (metallic taste), PRURITUS (itching) and MYALGIA (achy feeling in her upper body) had not resolved and NECK PAIN (Neck Ache) and URTICARIA (hives continued) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment reported.  No concomitant medication reported.   This case was linked to MOD-2021-265616 (Patient Link).   Reporter did not allow further contact
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain upper, Chills, Cough, Diarrhoea, Dyspnoea
Clinical narrative: sore throat; Maybe I have covid; cough; diarrhea; chills; aching here and there; shortness of breath; felt off; stomach cramps; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (felt off), ABDOMINAL PAIN UPPER (stomach cramps), DYSPNOEA (shortness of breath), CHILLS (chills) and OROPHARYNGEAL PAIN (sore throat) in a 51-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 7006320003 and 7006320006) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 20-Jul-2021, the patient experienced MALAISE (felt off) and ABDOMINAL PAIN UPPER (stomach cramps). On 21-Jul-2021, the patient experienced DYSPNOEA (shortness of breath). On 22-Jul-2021, the patient experienced CHILLS (chills), OROPHARYNGEAL PAIN (sore throat), SUSPECTED COVID-19 (Maybe I have covid), COUGH (cough), DIARRHOEA (diarrhea) and MYALGIA (aching here and there). At the time of the report, MALAISE (felt off), ABDOMINAL PAIN UPPER (stomach cramps), DYSPNOEA (shortness of breath), CHILLS (chills), OROPHARYNGEAL PAIN (sore throat), SUSPECTED COVID-19 (Maybe I have covid), COUGH (cough), DIARRHOEA (diarrhea) and MYALGIA (aching here and there) outcome was unknown.            Concomitant product use was not provided by the reporter.   No treatment information was provided.   Reporter did not allow further contact
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Malaise, Myalgia, Oropharyngeal pain, Suspected COVID-19
Clinical narrative: sore throat; Maybe I have covid; cough; diarrhea; chills; aching here and there; shortness of breath; felt off; stomach cramps; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (felt off), ABDOMINAL PAIN UPPER (stomach cramps), DYSPNOEA (shortness of breath), CHILLS (chills) and OROPHARYNGEAL PAIN (sore throat) in a 51-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 7006320003 and 7006320006) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 20-Jul-2021, the patient experienced MALAISE (felt off) and ABDOMINAL PAIN UPPER (stomach cramps). On 21-Jul-2021, the patient experienced DYSPNOEA (shortness of breath). On 22-Jul-2021, the patient experienced CHILLS (chills), OROPHARYNGEAL PAIN (sore throat), SUSPECTED COVID-19 (Maybe I have covid), COUGH (cough), DIARRHOEA (diarrhea) and MYALGIA (aching here and there). At the time of the report, MALAISE (felt off), ABDOMINAL PAIN UPPER (stomach cramps), DYSPNOEA (shortness of breath), CHILLS (chills), OROPHARYNGEAL PAIN (sore throat), SUSPECTED COVID-19 (Maybe I have covid), COUGH (cough), DIARRHOEA (diarrhea) and MYALGIA (aching here and there) outcome was unknown.            Concomitant product use was not provided by the reporter.   No treatment information was provided.   Reporter did not allow further contact
Sex: U
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: This spontaneous case reported by a patient, describes the occurrence of pyrexia (fever) in a patient, of an unknown age and gender, who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. No medical history reported. On an unknown date, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On an unknown date, patient experienced pyrexia (fever). At the time of the report, pyrexia (fever) outcome: unknown. The action taken with mRNA-1273 (Moderna COVID-19 vaccine): unknown. No concomitant medication or treatment information reported.
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Blood test, Muscle spasms
Clinical narrative: Joint pain; Muscle spasms; This spontaneous case was reported by a patient and describes the occurrence of MUSCLE SPASMS (Muscle spasms) and ARTHRALGIA (Joint pain) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026B21A and 047S21A) for COVID-19 vaccination.     No Medical History information was reported.   On 03-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1. On 29-May-2021, the patient experienced MUSCLE SPASMS (Muscle spasms). On 08-Jul-2021, the patient experienced ARTHRALGIA (Joint pain). The patient was treated with DIAZEPAM (VALIUM) for Adverse event, at an unspecified dose and frequency. At the time of the report, MUSCLE SPASMS (Muscle spasms) and ARTHRALGIA (Joint pain) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood test: normal (normal) normal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided.
Sex: U
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Vaccination site pain; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Vaccination site pain) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (Vaccination site pain). At the time of the report, VACCINATION SITE PAIN (Vaccination site pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Reporter did not allow further contact
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Dizziness, Fatigue, Feeling cold, Feeling hot
Clinical narrative: felt a little dizzy for a day or two; arm felt sore, warm, and was a little red at injection site; flu-like symptoms of warm then cold; flu-like symptoms of warm then cold/chilled; headache; tired; flu-like symptoms of body aches; arm little red at injection site; arm swollen at injection site; arm felt sore, warm, and was a little red at injection site; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (felt a little dizzy for a day or two), VACCINATION SITE WARMTH (arm felt sore, warm, and was a little red at injection site), FEELING HOT (flu-like symptoms of warm then cold), FEELING COLD (flu-like symptoms of warm then cold/chilled) and HEADACHE (headache) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 038A21A and 007M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Thyroiditis (Hashimoto Thyroiditis), Migraine headache, High cholesterol, Vitiligo and Dairy intolerance (Dairy sensitivity). Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) for an unknown indication, ROSUVASTATIN CALCIUM (CRESTOR).   On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 15-Mar-2021, the patient experienced VACCINATION SITE WARMTH (arm felt sore, warm, and was a little red at injection site), FEELING HOT (flu-like symptoms of warm then cold), FEELING COLD (flu-like symptoms of warm then cold/chilled), HEADACHE (headache), FATIGUE (tired), MYALGIA (flu-like symptoms of body aches), VACCINATION SITE ERYTHEMA (arm little red at injection site), VACCINATION SITE SWELLING (arm swollen at injection site) and VACCINATION SITE PAIN (arm felt sore, warm, and was a little red at injection site). On 30-Mar-2021, the patient experienced DIZZINESS (felt a little dizzy for a day or two). At the time of the report, DIZZINESS (felt a little dizzy for a day or two), VACCINATION SITE WARMTH (arm felt sore, warm, and was a little red at injection site), FEELING HOT (flu-like symptoms of warm then cold), FEELING COLD (flu-like symptoms of warm then cold/chilled), HEADACHE (headache), FATIGUE (tired), MYALGIA (flu-like symptoms of body aches), VACCINATION SITE ERYTHEMA (arm little red at injection site), VACCINATION SITE SWELLING (arm swollen at injection site) and VACCINATION SITE PAIN (arm felt sore, warm, and was a little red at injection site) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 15-Mar-2021, Body temperature: 99.6 f High.         Other Concomitant medicines included Multivitamin, Calcium + D3, Vit C, Vit E, fish oil, M Treatment information was not provided. Action taken with mRNA-1273 in response to the events was not applicable.   This case was linked to MOD-2021-028110, MOD-2021-028110 (Patient Link).
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site warmth
Clinical narrative: felt a little dizzy for a day or two; arm felt sore, warm, and was a little red at injection site; flu-like symptoms of warm then cold; flu-like symptoms of warm then cold/chilled; headache; tired; flu-like symptoms of body aches; arm little red at injection site; arm swollen at injection site; arm felt sore, warm, and was a little red at injection site; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (felt a little dizzy for a day or two), VACCINATION SITE WARMTH (arm felt sore, warm, and was a little red at injection site), FEELING HOT (flu-like symptoms of warm then cold), FEELING COLD (flu-like symptoms of warm then cold/chilled) and HEADACHE (headache) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 038A21A and 007M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Thyroiditis (Hashimoto Thyroiditis), Migraine headache, High cholesterol, Vitiligo and Dairy intolerance (Dairy sensitivity). Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) for an unknown indication, ROSUVASTATIN CALCIUM (CRESTOR).   On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 15-Mar-2021, the patient experienced VACCINATION SITE WARMTH (arm felt sore, warm, and was a little red at injection site), FEELING HOT (flu-like symptoms of warm then cold), FEELING COLD (flu-like symptoms of warm then cold/chilled), HEADACHE (headache), FATIGUE (tired), MYALGIA (flu-like symptoms of body aches), VACCINATION SITE ERYTHEMA (arm little red at injection site), VACCINATION SITE SWELLING (arm swollen at injection site) and VACCINATION SITE PAIN (arm felt sore, warm, and was a little red at injection site). On 30-Mar-2021, the patient experienced DIZZINESS (felt a little dizzy for a day or two). At the time of the report, DIZZINESS (felt a little dizzy for a day or two), VACCINATION SITE WARMTH (arm felt sore, warm, and was a little red at injection site), FEELING HOT (flu-like symptoms of warm then cold), FEELING COLD (flu-like symptoms of warm then cold/chilled), HEADACHE (headache), FATIGUE (tired), MYALGIA (flu-like symptoms of body aches), VACCINATION SITE ERYTHEMA (arm little red at injection site), VACCINATION SITE SWELLING (arm swollen at injection site) and VACCINATION SITE PAIN (arm felt sore, warm, and was a little red at injection site) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 15-Mar-2021, Body temperature: 99.6 f High.         Other Concomitant medicines included Multivitamin, Calcium + D3, Vit C, Vit E, fish oil, M Treatment information was not provided. Action taken with mRNA-1273 in response to the events was not applicable.   This case was linked to MOD-2021-028110, MOD-2021-028110 (Patient Link).